VTGN

VistaGen Therapeutics, Inc. Common Stock

$1.26 +$0.04 +3.17%



Shares Bought1
Shares Sold1
Total2
Shares Owned0
Last Price$1.26
Total Return$0.12
Range Today$1.20 - $1.26
52 Week Range$0.69 - $3.71
Open$1.21
Market Cap$14.65M
Volume/Average397.46K/446.08K
P/E Ratio-
Dividend/Yield-




VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative product candidates for patients with diseases and disorders involving the central nervous system. Its product candidate, AV-101, is a next generation, orally available prodrug candidate in Phase 2 development, initially for the adjunctive treatment of Major Depressive Disorder in patients with an inadequate response to standard antidepressants. The company was founded by H. Ralph Snodgrass and Gordon Keller on May 26, 1998 and is headquartered in South San Francisco, CA.


Open Positions

Buy Date Buy Price Quote Return $ Return % Owners

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
17-12-06 16:12 17-12-06 19:30 $2.10 $2.22 +$0.12 +5.76% pineapqle